Other ·Strong evidence ·Reviewed May 2026
Sugar alcohol involved in insulin signaling and neurotransmitter function.
The bottom line
Evidence rating strong. Most-documented uses: pcos support, anxiety reduction, insulin sensitivity. 21 sources indexed (1995–2025), with 9 interaction records on file.
Core mechanism
Component of phosphatidylinositol (PI) cell signaling. Myo-inositol is a second messenger for insulin, serotonin, and FSH receptors. D-chiro-inositol supports insulin sensitivity.1,2
Take in divided doses; powder mixes easily in water9,2
Dosing protocol
40:1 myo to D-chiro ratio is best studied for PCOS. Higher doses (4-12 g) for mood.9
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Myo-Inositol Powder.
Assumes 2-4 g/day. Vendor basis: BulkSupplements powder, NOW/iHerb, Vitacost, and Amazon marketplace; 40:1 myo/D-chiro blends price higher. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Food inositol content varies and is often bound as phytate.
What to test, the optimal window inside the conventional range, and how long a response takes.
Myo-inositol (2 g twice daily) plus D-chiro-inositol (50 mg twice daily) lowers HOMA-IR and improves ovulation in PCOS over 12 weeks.14,1
PCOS-specific: also track AMH, free testosterone, SHBG. Pair with fasting glucose and insulin.
Inositol (commonly myo-inositol) may modestly lower fasting insulin in PCOS and insulin resistance, with effects that are typically dose-dependent and most pronounced when baseline insulin or insulin resistance is elevated.8,12
Requires an 8 to 12 hour overnight fast and is best paired with fasting glucose to calculate HOMA-IR. Insulin assays vary between labs, so use the same lab for serial comparisons and retest after at least 12 weeks.
Inositol (typically myo-inositol, sometimes paired with D-chiro-inositol) tends to lower fasting triglycerides in people with insulin resistance or PCOS, likely by improving insulin signaling, which in turn reduces hepatic production of triglyceride-rich particles. The effect is modest and the data are emerging, with the clearest signal in insulin-resistant and PCOS populations rather than in metabolically healthy people, so treat any reduction as preliminary rather than guaranteed.1,2
Measure triglycerides on a true fasting sample, ideally 9 to 12 hours without food and after avoiding alcohol for 1 to 2 days, since recent meals and drinking can transiently inflate the number and mask any effect. Timing of the inositol dose relative to the blood draw matters little; consistency of daily use over the weeks before testing matters far more, so keep diet, exercise, and dose stable in the run-up to a retest to get a clean before-and-after comparison. Because triglyceride results are tied to metabolic and cardiovascular health, and because inositol is most relevant for people with PCOS or insulin resistance who may also be on diabetes medication, involve a clinician to interpret results, confirm the supplement fits your overall plan, and watch for any interaction with glucose-lowering drugs.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Myo-inositol and D-chiro-inositol act as insulin second messengers and may improve insulin sensitivity, ovulation, and androgen profiles in PCOS.5,13
Effects on cycle regularity typically take about 3 months.
Myo-inositol can improve insulin signaling and ovarian function, which may help restore ovulation and cycle regularity in PCOS-related irregularity.8,12
Most relevant when irregular cycles are linked to PCOS; allow about 3 months to assess.
Myo-inositol feeds into serotonin and other second-messenger signaling pathways, and a few small trials suggest high doses may reduce panic attack frequency.17,18
Adjunct only: recurrent panic attacks warrant evaluation by a clinician for panic disorder and evidence-based therapy.
Myo- and D-chiro-inositol act as second messengers in insulin signaling and may improve insulin sensitivity, especially in PCOS-related insulin resistance.8,12
The 40:1 physiologic ratio has the best PCOS evidence, and effects typically build over 8 to 12 weeks.
Myo-inositol may improve insulin sensitivity and egg quality and can support ovulation, especially in PCOS-related subfertility.8,12
Most relevant with PCOS or irregular ovulation; allow about 3 months.
Inositol is commonly used in anxiety and panic-focused protocols because of effects on cell signaling and neurotransmission.17,15
Large doses are often used in formal studies, so start lower for GI tolerance.
Inositol modulates serotonergic signaling; small RCT evidence in mood disorders and PMS.1,2
High doses required for mood; PCOS doses are lower.
Inositol is a second-messenger precursor in serotonergic signaling, with some evidence for reducing anxiety and mood symptoms.1,2
Effective doses are often several grams daily; introduce gradually to limit GI upset.
Inositol participates in insulin and serotonin signaling, so it may support mood and appetite regulation where insulin resistance or PCOS coexists.1,2
Most relevant when emotional eating overlaps with PCOS or blood-sugar swings.
Myo-inositol acts as a second messenger in insulin signaling and may improve insulin sensitivity, with most evidence in insulin-resistant and PCOS populations rather than reactive hypoglycemia directly.1,2
Benefit here is extrapolated; discuss with a clinician if crashes are frequent or severe.
Myo-inositol acts as an insulin-signaling second messenger and has improved insulin and lipid markers in metabolic studies.5,1
The strongest evidence is in PCOS; broader metabolic-syndrome data are still developing.
Myo- and D-chiro-inositol act in insulin second-messenger pathways and may improve insulin sensitivity in insulin-resistant states.2,6
The strongest data are in PCOS and gestational settings; direct type 2 diabetes evidence is still developing.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
40:1 myo to D-chiro ratio improves insulin sensitivity and ovulation in PCOS; benefits extend to general insulin resistance.8,12
Myo-inositol is a precursor for the phosphatidylinositol second-messenger system that operates downstream of certain serotonin and insulin receptors. Evidence in premenstrual syndrome and premenstrual dysphoric disorder is limited and inconsistent (one small trial found no benefit in PMDD), so it is best viewed as optional and most relevant when cycles are also affected by insulin-related irregularity.1,2
Myo-inositol acts as a second messenger in insulin and FSH signaling and may support more regular ovulation, with the strongest signal in people who have features of PCOS. It is supportive rather than curative, and PCOS care should be guided by a clinician.8,12
Inositol contributes to second messenger pathways involved in insulin signaling and may support insulin sensitivity, with the clearest data in women who have insulin resistance patterns such as PCOS. Any effect on appetite is indirect and the supporting evidence is still developing, so it is included as supportive rather than essential.1,2
Inositol improves insulin sensitivity in PCOS; berberine improves it via AMPK activation. Combined effect on HOMA-IR, fasting glucose, and ovulation may be additive in PCOS.
Recommendation: Combine for PCOS and metabolic syndrome with insulin resistance. Monitor fasting glucose, A1c, and (in PCOS) AMH and ovulation.
Inositol counteracts part of lithium's proposed mechanism by replenishing the inositol pool that lithium depletes, which may blunt lithium's mood-stabilizing effect when the two are used together.
Recommendation: Be cautious combining the two if lithium is being used for mood stabilization. Discuss with a clinician, since high-dose inositol may oppose lithium's intended action.
In polycystic ovary syndrome, myo-inositol and N-acetylcysteine target complementary problems: inositol supports insulin signaling while NAC provides antioxidant support and can improve ovulatory response.
Recommendation: Reasonable to combine in a PCOS or insulin-resistance context. Typical research dosing is myo-inositol around 2g to 4g daily with NAC 600mg to 1800mg daily, ideally guided by a clinician.
Adequate vitamin D status appears to improve the metabolic and reproductive response to myo-inositol in PCOS, and the two are frequently combined to support insulin sensitivity and ovulation.
Recommendation: Correct vitamin D deficiency (aim for a sufficient serum 25-OH-D) when using inositol for PCOS or insulin resistance, since low vitamin D may blunt the inositol response.
Myo-inositol and chromium each support insulin sensitivity through different routes, so combining them may give additive benefit on fasting insulin and glycemic control in insulin-resistant states such as PCOS.
Recommendation: Reasonable to combine for insulin resistance. Common amounts are myo-inositol 2g to 4g daily with chromium (as picolinate) 200mcg to 1000mcg daily; monitor glucose if also taking diabetes medication.
Both combined oral contraceptives and inositol (myo-inositol) are used for PCOS, but for different reasons. COCs treat hyperandrogenism and regulate cycles by suppressing ovulation, while inositol improves insulin sensitivity and may restore ovulation. The two can be used together, but pregnancy will not occur while on the pill, so women trying to conceive should switch from COC to inositol rather than combine them.
Recommendation: Inositol (typically myo-inositol 2 g twice daily, often with 50 mg of D-chiro-inositol) can be taken alongside combined oral contraceptives to address PCOS-related insulin resistance. Discuss with your clinician whether the pill is still needed or whether inositol alone might suit your reproductive goals.
Myo-inositol and D-chiro-inositol act as second messengers downstream of the insulin receptor and improve insulin sensitivity, fasting glucose, and HOMA-IR in PCOS and type 2 diabetes. Network meta-analyses suggest myo-inositol combined with metformin outperforms metformin alone for several metabolic endpoints in PCOS. The combination is generally beneficial, with low hypoglycemia risk because metformin and inositol both act as insulin sensitizers rather than insulin secretagogues.
Recommendation: If you take metformin for PCOS or insulin resistance, adding myo-inositol (commonly 2-4 g daily) is generally safe and may improve glycemic and reproductive outcomes. Continue routine glucose monitoring; severe hypoglycemia is unlikely unless you also take insulin or a sulfonylurea.
Myo-inositol and D-chiro-inositol improve insulin sensitivity and lower fasting glucose. Glipizide forces pancreatic insulin secretion. Combined, the additive glucose-lowering can produce hypoglycemia, particularly in older adults or after missed meals.
Recommendation: Tell your prescriber before starting inositol on glipizide. Monitor fingerstick glucose more often during the first 2-4 weeks and ask whether the glipizide dose should be reduced.
Myo-inositol and D-chiro-inositol improve insulin sensitivity and can lower fasting glucose. Insulin glargine provides 24-hour basal insulin coverage. Combined, the additive glucose-lowering can produce nocturnal hypoglycemia, particularly during the first weeks after starting inositol.
Recommendation: Tell your prescriber before starting inositol on insulin glargine. Check fasting and bedtime glucose more often for the first 2-4 weeks and discuss whether your glargine dose should be reduced.
Numbered references. Citations throughout the page link here.
Kelly FA, de Oliveira Macena Lôbo A, Cardoso JHCO et al.. Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Endocrine. 2025
Wang RT, Feng YQ, Wang MY et al.. Efficacy of inositol supplementation in the prevention and treatment of gestational diabetes mellitus: A meta-analysis. World journal of diabetes. 2025
Evidence supporting the use of inositol in PCOS management is limited and inconclusive, though some benefits noted for specific outcomes.
Combined selenium and myo-inositol supplementation was more effective than selenium alone in improving thyroid function and reducing thyroid antibodies in autoimmune thyroiditis patients.
Myo-inositol is effective and safe for PCOS; causes fewer GI adverse events than metformin and improves metabolic profile with reduced hyperandrogenism.
Myo-inositol supplementation during pregnancy may reduce the risk of developing gestational diabetes mellitus, though the certainty of evidence was rated as low to moderate.
Factor PA, Corpuz H. The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. Journal of the ASEAN Federation of Endocrine Societies. 2023
Myo-inositol supplementation significantly reduced the incidence of gestational diabetes mellitus and improved insulin sensitivity in pregnant women.
Inositol supplementation significantly reduced BMI, particularly in women with PCOS, with greater effects observed at higher doses and longer durations.
Li L, Fang J. Myo-inositol supplementation for the prevention of gestational diabetes: A meta-analysis of randomized controlled trials. European journal of obstetrics, gynecology, and reproductive biology. 2022
Pani A, Giossi R, Menichelli D et al.. Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation. Nutrients. 2020
Inositol supplementation decreases blood glucose through improvement in insulin sensitivity independent of weight.
Myo-inositol had beneficial effects improving the metabolic profile of women with PCOS and reducing hyperandrogenism.
Four RCTs in anxiety disorders (70 patients) found no statistically significant effects of inositol; more robust trials needed.
Frequency and severity of panic attacks and agoraphobia declined significantly more after inositol than placebo, with minimal side effects.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack